Your institution may have access to this item. Find your institution then sign in to continue.
Title
Hepatic safety of once-monthly injectable extended-release naltrexone administered to actively drinking alcoholics.
Authors
Lucey, Michael R; Silverman, Bernard L; Illeperuma, Ari; O'Brien, Charles P
Abstract
Hepatoxicity has been reported with oral naltrexone. Hepatic safety data were examined from a 6-month study evaluating the efficacy and safety of a now available extended-release formulation of naltrexone (XR-NTX) in patients with alcohol dependence.